in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Premier Pneumatics, GE Healthcare and WaterSep.
Capsule specialist Capsugel has won the contract to make a highly-touted new anti-inflammatory developed by French biotechnology company NicOx as the product approaches registration.
US contract research organisation Encorium Group has postponed its planned acquisition of Prologue Research International and cut staff in the latest twist in a rollercoaster ride for the firm in recent weeks.
Clinical trials that support the effectiveness of drugs filed for approval in the US are more likely to be published than those that are less supportive, according to researchers at the University of California at San Francisco.
Ranbaxy’s antiretrovirals zidovudine, lamivudine, and nevirapine have been removed from PEPFAR’s list of approved products until ongoing GMP problems at two of the firm’s Indian manufacturing plants are resolved.
UK-based automation expert, Astech Projects, has been signed up to assist a ‘top 5 pharmaceutical company’ just months after launching its new automation maintenance service.
BioTrove has launched a series of assay panels that enable researchers to skip the laborious initial steps of gene selection and assay optimisation and start studying disease pathways straightaway.
Indian pharmaceutical companies are making their first forays in the biotechnology arena, helping the market expand from a standing start at the beginning of the decade to reach a value of $2bn in 2006-7, according to a recent report from KPMG.
TTP LabTech has transformed its ‘mosquito’ nanolitre liquid handler into a highly flexible system for preparing microplates for high throughput (HT) screening applications.
Teva and Kowa have set their sights on Japan’s $4.6bn (€3.1bn) generics market with their development and manufacturing joint venture Teva-Kowa Pharma.
UK-based Melbourn Scientific is now offering an integrated package of formulation, method development, analysis and short-run clinical manufacture services to industrial clients.
Pharmaceutical companies on both sides of the Atlantic are facing a particularly difficult time over the next 12 to 18 months, according to a report by financial research and analysis company Moody’s.
Alpharma has licensed an investigational transdermal bupivacaine patch from Durect for an initial $20m, with further payments based on reaching developmental milestones.
Indian pharmaceutical company Lupin Ltd has expanded into Africa by acquiring a 60 per cent stake Pharma Dynamics, a generics company and contract manufacturer based in Cape Town, South Africa.
in-PharmaTechnologist.com’s periodic round-up of developments in the pharmaceutical manufacturing space includes news on MannKind, Nycomed, ABS and Tris.
Prosonix, a specialist developer of ultrasonic industrial processing solutions, says that global drug giant Pfizer is to begin using its Prosonitron reactor and sonocrystallisation technology at its manufacturing facility in Ireland.
A domino effect appears to have been started by the FDA blocking Ranbaxy imports, with other regulatory bodies paying close attention to the generics giant.
The WHO has issued Sandoz with a Notice of Concern (NoC) after an inspection of the firm’s Kempton Park facility in South Africa identified 41 deviations from GMP standards.
US CRO group Encorium has signed new contracts worth around $6.2m (€4.1m) under which it will conduct trials of a developmental vaccine on behalf of a global biopharmaceutical company.
Sanofi-Aventis’ €1.8bn ($2.6bn) offer for Czech generics firm Zentiva has been unanimously accepted by the latter firm’s board after four months of wrangling that has seen the bid increase by 9.5 per cent.
China is the ideal destination for outsourcing, according to a report by PricewaterhouseCoopers (PwC) that has calculated rankings based on a range of parameters.
Ion channel expert ChanTest is expanding its range of ion channel services and cell lines that help identify promising target compounds and those that could cause harmful side effects.
Phylogeny has launched the first microRNA (miRNA) in situ hybridisation detection service to help scientists delve deeper into the mechanisms controlling key biological processes.
Germany-based Diapharm has launched a service allowing pharmaceutical manufacturers to perform joint third-party audits of active pharmaceutical ingredients (APIs).
Dutch chemicals giant DSM and France’s LibraGen are targeting the chemical and pharmaceutical industries with their new chiral amine production accord, which aims to develop a range of new catalytic enzymes.
Massachusetts needs to do more to produce workers for its life sciences industry if it is to avoid a skills shortage in years to come, according to research.
UK-based Reaxa and Switzerland’s RohnerChem have teamed up to develop the former’s EnCat catalyst technology for industrial applications in the API and drug manufacturing sector.
EnWave says that its freezeREV dehydration technology can reduce the moisture content of single vial vaccines to between 3 and 3.5 per cent, bettering the mark achieved by its bioREV platform.
Active pharmaceutical ingredient specialist Calyx Chemicals and Pharmaceuticals is planning an acquisition within the next two years, probably in the US or Europe, according to chief executive Smitesh Shah.
Despite the credit crunch, Invitrogen’s acquisition of ABI (Applied Biosystems) is expected to be complete by early November and details of how the merged entity will be structured have just been released.
UK-based deltaDOT has launched a new assay that dramatically reduces the time needed to quantify the number of baculovirus expression vectors present in a sample.
European researchers have devised a method of purifying parasites that will enable scientists to gain deeper insights into the biology of the organisms responsible for millions of infections every year.
UK-based Pharmaceutical Profiles has used an imaging technique known as scintigraphy to quantify the effects of Amylin / Eli Lilly’s latest diabetes drug on the stomach.
Oral dose filling specialist Capsugel hopes that its new Xcelohood containment system will improve industrial weighing operations during the preparation of high-potency drugs.
DSM Biomedical and Caliber Therapeutics aim to expand their presence in the balloon catheter market with a project to develop new drug delivery devices for vascular diseases, including atherosclerosis.
IPEC China must become a “harmonisation bridge between China and other countries,” according to Colorcon’s Nevin Cheng who was recently elected chairman of the new organisation.
CMO NextPharma has signed a deal to make Aseptic Technologies “revolutionary” ‘closed-vial’ filling system available as part of its offering to clients.
Pharmatek Laboratories has opened its highly-potent and cytotoxic facility located in San Diego, US, just over a year after announcing its move into this growth area of contract manufacturing.
Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.
